Question
stringlengths 13
1.05k
⌀ | Answer
stringlengths 2
801
⌀ |
---|---|
What does the classification regulation designate this guidance document as?
|
the special control
|
What does the firm need to show that its device addresses the issues of safety and effectiveness identified in this guidance?
|
The firm will need to show that its device addresses the issues of safety and effectiveness
|
What are biomarker tests that rely on biological imaging assessments called?
|
MRI
|
What must a manufacturer do to ensure the safety and effectiveness of full-field digital mammography devices?
|
conform to the general controls of the FD&C Act, including the premarket notification requirements
|
What is the 21 CFR 807 Subpart E of the 21 CFR 807 Subpart E of the 21 CFR 807 Subpart E of the 21 CFR 807.81?
|
21 CFR 807.87
|
What is the scope of this document limited to?
|
FFDM systems
|
What is a full-field digital mammography system intended to produce?
|
planar digital x-ray images of the entire breast
|
What is the FDA guidance document entitled?
|
Class II Special Controls Guidance Document: Full-Field Digital Mammography System
|
What is the acquisition work station used for?
|
acquisition work station
|
What is the detector readout device?
|
removable solid state detector
|
What is the class of devices that display accessories to an FFDM System?
|
class II
|
What should you identify your device by in a 510(k) premarket notification?
|
regulation and product code
|
What is the (device name) intended to be used in the same clinical applica?
|
The (device name)
|
What may require longer periods of time to evaluate?
|
clinically meaningful outcomes
|
What is the screening use of an FFDM system?
|
An FFDM system can be indicated for screening use only or for both screening and diagnostic uses
|
What is the amorphous silicon with deposit of cesium iodide?
|
cesium iodide
|
What is the size of active area?
|
pixel dimensions and fill factor
|
What is the flat-field correction procedure called?
|
the flat-field correction procedure
|
What is the ADC?
|
bit depth, matrix size, and pixel width
|
What is SID?
|
source to patient support device distance
|
What should you describe for the x-ray tube if manufactured by a third party?
|
trade name and model
|
What is the AEC detector used for?
|
low level pre-exposure
|
What is acceptable if an alternative method is chosen?
|
it should be described completely
|
What should describe the paddle types, sizes, geometries, and materials?
|
breast compression system
|
What should be well established evidence and agreement in the clinical community that the chosen biomarker test reflects a characteristic that is important to 6 the underlying disease process and that it is associated with a?
|
the chosen biomarker test
|
What is the level of concern?
|
the risks associated with software failure
|
What is the replacement for film cassettes for detectors intended to be used with conventional mammographic x-ray systems?
|
computed radiography (CR) plate/reader/display systems
|
What is the radiation dose a function of?
|
breast thickness and composition
|
What measures are described in this guidance document?
|
measures recommended to mitigate these identified risks
|
What is the name of the standard that should be used to evaluate the electrical safety of your device?
|
Clinical Image Evaluation 8. Physical Laboratory Testing Inadequate breast coverage 9. Clinical Image Evaluation Excessive x-ray exposure 8. Physical Laboratory Testing Inappropriate breast compression 8. Physical Laboratory Testing 7. Biocompatibility Testing Infection, skin irritation 10. Labeling 6. Electrical Safety You should evaluate the electrical safety of your device according to the following standards or use equivalent me Answer:
|
What is the Collateral standard?
|
Safety requirements for medical electrical systems
|
What should you assess in your physical laboratory?
|
imaging characteristics of your system
|
What should you describe as general guidance for these tests?
|
all phantoms
|
What is a phantom?
|
Mammography Accreditation Program (MAP) phantom
|
What should be performed under conditions that match the intended clinical use of the system?
|
testing
|
What is the system code NFJ?
|
System, Image Management, Ophthalmic
|
What is the MDDT program?
|
The FDA’s Medical Device Development Tools
|
What should you report if you were to assess imaging performance?
|
the trade name, characteristics
|
What should you provide quantitative data on?
|
sensitometric response
|
What is the NPS?
|
noise power spectrum
|
What is the measure of the efficiency of signal-to-noise ratio?
|
SNR
|
What is the exposure level chosen from those used in clinical practice called?
|
the “reference” level
|
What should you provide a quantitative measure of?
|
dynamic range
|
What is a function of the number of erasures and exposures?
|
tests of image retention
|
What should you provide results of with 100 or more repeated exposures and erasures showing that there are no residual or ghost images?
| null |
What should you provide results of with 100 or more repeated exposures and erasures showing that there are no residual or ghost images?
|
Repeated Exposure Test
|
What should you provide to evaluate AEC performance?
|
data sets for a range of thicknesses from 2 to 6 cm of a homogeneous material at standard mode and magnification mode if available
|
What should be provided for imaging of the ACR MAP phantom and for the wax target plate of the phantom?
| null |
What should clinical outcome assessments consist of?
|
direct quantitative measurement of the effect of a treatment upon disease progression and its impact upon the patient
|
What should be included in the results of the AEC system if it has more than one mode of operation?
|
Exposure conditions and dose
|
What is a C-D diagram?
|
a plot of the minimum detectable target thickness or contrast as a function of target size
|
What is the k factor not greater than?
|
80 m2
|
What is the minimum exposure level for FFDM devices?
|
21 CFR 892.1950
|
What should your testing simulate?
|
2, 4.2, and 6 cm thick compressed breasts
|
What is the resulting patient radiation dose?
|
exposure level at the entrance surface of the phantom along with the resulting patient radiation dose
|
What is the minimum and maximum powered compression?
|
Breast Compression System
|
What is the purpose of this evaluation?
|
to determine if the FFDM images, when reviewed by expert radiologists, are judged to be of sufficiently acceptable quality for mammographic usage that they are substantially equivalent in safety and effecti
|
What is the new device substantially equivalent in safety and effectiveness to?
|
laboratory performance of the predicate device
|
What are the names of the craniocaudal and mediolateral oblique views?
|
craniocaudal (CC) and mediolateral oblique (MLO) views
|
What should be considered when developing clinical effectiveness endpoints?
|
The patient population, the nature of the underlying condition, and how they will be studied over time
|
How many expert mammographic radiologists should review clinical images submitted for MQSA accreditation?
|
two
|
What is the verall assessment of whether these image sets collectively are of sufficiently acceptable quality for use in clinical mammography and to allow determination of substantial equivalence to a predicate device?
|
breast positioning
|
What should the associated information include for each image?
|
compressed breast thickness, x-ray exposure conditions (anode, filter, kVp, mAs, exposure, half-value layer), and estimated dose
|
What should be fully explained by the expert mammographic radiologists?
|
mammography quality control manual
|
What must labeling satisfy?
|
21 CFR 807.87(e)
|
What should be discussed with the precautions regarding the potential for adverse events associated with the use of the device and mitigation measures?
|
The adverse events should include: • excessive breast compression; • excessive x-ray exposure; • electric shock; • infection; and • skin irritation, abrasions or puncture wounds
|
What should you list for detector-only systems?
|
the x-ray system specifications and performance requirements
|
What is the purpose of the ation dose?
|
to be used to verify proper AEC performance
|
What should you include a summary of?
|
sensitometric response
|
What is the patient population used for?
|
age, ethnic origin
|
What should labeling of the device be consistent with?
|
manner in which it was studied
|
What should be encouraged in the instructions?
|
local/institutional training programs
|
What is the AEC?
|
Automatic Exposure Control
|
How long have you been practicing radiology since residency?
|
at least five years
|
What is the name of the department that evaluates Cardiovascular Devices?
|
Food and Drug Administration Center for Devices and Radiological Health Office of Device Evaluation Division of Cardiovascular Devices Cardiac Electrophysiology and Monitoring Branch 1 Preface Public Comment: What is the name of the department that evaluates Cardiovascular Devices
|
Where can you submit electronic comments for Agency consideration?
|
Division of Dockets Management, Food and Drug Administration
|
Where can you get ional copies of the guidance?
|
the Internet
|
What does not apply to electrodes or dispersive pads used for defibrillation, pacing, or cardioversion?
|
This guidance
|
What does this guidance document describe?
|
a means by which ECG electrodes may comply with the requirement of class II special controls (513(a)(1)(B) of the act
|
What must a manufacturer submit to provide equivalent assurances of safety and effectiveness?
|
a 510(k)
|
What must a class II device comply with as a class II device?
|
general and special controls
|
What is a disease-altering benefit?
|
treatment of the underlying disease or condition
|
What does FDA recommend that manufacturers document how they address the recommendations in their design history file?
|
how they address the recommendations in this special controls guidance
|
Who does not need to submit a 510(k) to FDA and receive agency clearance prior to marketing a device of this type?
|
persons who intend to market a device of this type
|
What is the scope of this document limited to?
|
ECG electrodes
|
What are generally used to deliver a small amount of alternating current with a high frequency?
|
Bioimpedance electrodes
|
What is the scope of electrodes used for?
|
external pacing or other treatment effect
|
What is the FDA recommend to mitigate the risks identified in this guidance document?
|
5 Recommended mitigation measures Identified risk Adverse tissue reactions to the skin-contacting Section 5. Performance Characteristics electrode materials Section 6. Labeling Section 5. Performance Characteristics Misdiagnosis Section 6. Labeling Section 5. Performance Characteristics Electrical shock 21 CFR 898 P Answer: FDA has identified the following risks to health associated with the use of the ECG electrode.
|
What must you maintain for each type of device?
|
device specifications, including appropriate drawings
|
What should be included in the cription?
|
a listing of all features and specifications of the device (a tabular format is desirable)
|
What is the 21 CFR 820.20?
|
Quality Systems Requirements
|
What is the type of electrodes?
|
bare
|
What is the FDA's recommendation for early engagement with CDRH?
|
to obtain more detailed feedback
|
What should not cause an irritating, sensitizing or cytotoxic effect upon the skin?
| null |
What should not allow irritating sensitizing, or cytotoxic materials to enter the skin by iontophoresis?
|
electrodes
|
What is the electrolytic composition of some electroconductive gels that contain high levels of saline?
|
saline
|
What should the design of the electrode ensure?
|
it will adhere to the patient’s skin for the duration of use compatible with the intended use of the device
|
What do you test if the electrode is intended to be used on a diaphoretic patient or during strenuous exercise?
|
adhesive performance
|
What should monitor the critical parameters of your final finished disposable ECG electrode to assure adequate device performance during its entire shelf-life?
|
Stability studies
|
What should be supported and validated by real-time shelf life testing?
|
accelerated shelf life testing
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.